The concept of CXO is all turned red, and the bottom of the medical ETF (512170) is rising

In the early morning of the 14th, the CXO sector continued to oscillate and stretch it after opening and low. Jiuzhou Pharmaceutical once rose more than 5%. Kang Longhua became nearly 3%.Near the market closing the market, the largest medical ETF (512170) declines narrowed to 0.41 %, and the turnover was 420 million yuan. The early trading fell 1.83 %of the set of 0.481 yuan and 29 months.

According to the latest performance data, the performance of the Chinese Stock Exchange Medical Index continued to maintain a high -speed growth in the first half of 2022. The main business income growth rate of the main business of the sector was 42%according to the overall method, and the net profit growth rate was 45%. Among them, the concept of CXO was the most high.The total net profit of the 8 CXO concepts of the CSI Medical Index exceeded 10.3 billion yuan, an increase of more than 82%compared to 2021!

- END -